Chief Scientific Officer, Salimetrics LLC
Dr. Steve Granger is Chief Scientific Officer at Salimetrics, LLC. He earned his Ph.D. in Molecular Biology and Biochemistry at the University of California, Irvine, followed by post-doctoral training at the La Jolla Institute for Allergy & Immunology, where his research efforts focused on the immunobiology of the tumor necrosis family (TNF) superfamily. Dr. Granger spent many years in the biotechnology industry working at Tanabe Research Laboratories USA, Inc. as a Senior Director of research and at Kyowa Hakko Kirin California as a Senior Research Scientist. During this time, he managed preclinical biologic drug development programs for the treatment of autoimmune and chronic inflammatory disorders. Additionally, he led several drug discovery projects for the treatment of osteo- and rheumatoid arthritis, as well as inflammatory bowel disease. One fully human monoclonal antibody identified from these studies is in clinical trials for chronic inflammatory diseases. Dr. Granger is currently leading the R&D team at Salimetrics, LLC. generating new oral fluid diagnostic assays.